These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34071523)

  • 21. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
    Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
    Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of carbonic anhydrase 9 gene polymorphism on the progression of colorectal cancer.
    Huang HC; Shiu BH; Nassef Y; Huang CC; Chou YE; Ting WC; Chang LC; Lin JC; Hsiao LK; Yang SF; Su SC
    J Cancer; 2022; 13(9):2775-2780. PubMed ID: 35812185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of single nucleotide polymorphisms in the coding region of Bcl-2 with the occurrence and prognosis of colorectal cancer: A case-control study.
    Huang B; Liu X; Sun C; Wang L; Yang L
    Cancer Biomark; 2017; 18(4):433-439. PubMed ID: 28106544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
    Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T
    Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas.
    Wimmer E; Ihrler S; Gires O; Streit S; Issing W; Bergmann C
    World J Clin Oncol; 2019 Mar; 10(3):136-148. PubMed ID: 30949443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
    Banday MZ; Sameer AS
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
    [No Abstract]   [Full Text] [Related]  

  • 27. Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension.
    Al-Daghri NM; Mohammed AK; Al-Attas OS; Draz HM; Alokail MS
    Genet Test Mol Biomarkers; 2017 Jul; 21(7):422-427. PubMed ID: 28650667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.
    Choi KY; Rho YS; Kwon KH; Chung EJ; Kim JH; Park IS; Lee DJ
    Cancer Biomark; 2012-2013; 12(3):115-24. PubMed ID: 23481570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
    Bange J; Prechtl D; Cheburkin Y; Specht K; Harbeck N; Schmitt M; Knyazeva T; Müller S; Gärtner S; Sures I; Wang H; Imyanitov E; Häring HU; Knayzev P; Iacobelli S; Höfler H; Ullrich A
    Cancer Res; 2002 Feb; 62(3):840-7. PubMed ID: 11830541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.
    Quintanal-Villalonga Á; Carranza-Carranza A; Meléndez R; Ferrer I; Molina-Pinelo S; Paz-Ares L
    Clin Lung Cancer; 2017 Nov; 18(6):667-674.e1. PubMed ID: 28583379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation.
    Whittle SB; Reyes S; Du M; Gireud M; Zhang L; Woodfield SE; Ittmann M; Scheurer ME; Bean AJ; Zage PE
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):131-8. PubMed ID: 26840079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast Growth Factor 19-Mediated Up-regulation of SYR-Related High-Mobility Group Box 18 Promotes Hepatocellular Carcinoma Metastasis by Transactivating Fibroblast Growth Factor Receptor 4 and Fms-Related Tyrosine Kinase 4.
    Chen J; Du F; Dang Y; Li X; Qian M; Feng W; Qiao C; Fan D; Nie Y; Wu K; Xia L
    Hepatology; 2020 May; 71(5):1712-1731. PubMed ID: 31529503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics.
    Huang HC; Shiu BH; Su SC; Huang CC; Ting WC; Chang LC; Yang SF; Chou YE
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between fibroblast growth factor receptor 4 Gly388Arg polymorphism and ischaemic stroke.
    Zhang HF; Zhao KJ; Yang PF; Fang YB; Zhang YH; Liu JM; Huang QH
    J Int Med Res; 2012; 40(5):1708-14. PubMed ID: 23206452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.
    da Costa Andrade VC; Parise O; Hors CP; de Melo Martins PC; Silva AP; Garicochea B
    Exp Mol Pathol; 2007 Feb; 82(1):53-7. PubMed ID: 17084840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer.
    Hu L; Cong L
    Oncol Rep; 2015 Nov; 34(5):2683-91. PubMed ID: 26323668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma.
    Yang Y; Zhou Y; Lu M; An Y; Li R; Chen Y; Lu DR; Jin L; Zhou WP; Qian J; Wang HY
    Mol Carcinog; 2012 Jul; 51(7):515-21. PubMed ID: 21656577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
    Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA
    Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Kim JH; Jeong SY; Jang HJ; Park ST; Kim HS
    Front Oncol; 2021; 11():762528. PubMed ID: 34737965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.